Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

The United States patent system underwent a significant change with the enactment of the First-Inventor-to-File (FITF) ...

Subsequent court rulings clarified that under current U.S. law, only humans can be listed as inventors, but they left open ...

Not until I enrolled in as many IP courses and seminars as my law school offered did I realize how far reaching the full ...

Opinion: Howard & Howard's Joseph Barber says companies need to decide whether patent or trade secret protection will better ...

By Alberto Alerigi SAO PAULO (Reuters) -Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide ...

Company’s 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive position as it prepares for planned ...

As a patent trial lawyer and IP attorney, one question clients frequently ask is, “Why should we build a patent portfolio?” ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Netforce announces the granting of a second patent in the United States, Patent number: US 12 222 193 B2, ensuring the ...

Company's 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company's competitive position as it prepares for planned ...